Selected research
Industry Research
Over the Counter (OTC) Analgesics Industry Research Report 2026
Market perspective
The global Over the Counter (OTC) Analgesics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Over the Counter (OTC) Analgesics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Over the Counter (OTC) Analgesics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Over the Counter (OTC) Analgesics include Takeda Pharmaceutical Company Limited., Sanofi SA, Johnson & Johnson, Novartis, Pfizer, Bayer AG, AstraZeneca, Sun Pharma and Reckitt Benckiser Group PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Over the Counter (OTC) Analgesics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Over the Counter (OTC) Analgesics Market by Company
Takeda Pharmaceutical Company Limited.
Sanofi SA
Johnson & Johnson
Novartis
Pfizer
Bayer AG
AstraZeneca
Sun Pharma
Reckitt Benckiser Group PLC
GlaxoSmithKline PLC
Boehringer Ingelheim International GmbH
Over the Counter (OTC) Analgesics Segment by Type
Tablet
Capsule
Other
Over the Counter (OTC) Analgesics Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Over the Counter (OTC) Analgesics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Over the Counter (OTC) Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Over the Counter (OTC) Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Other
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Takeda Pharmaceutical Company Limited.
- Sanofi SA
- Johnson & Johnson
- Novartis
- Pfizer
- Bayer AG
- AstraZeneca
- Sun Pharma
- Reckitt Benckiser Group PLC
- GlaxoSmithKline PLC
- Boehringer Ingelheim International GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Over the Counter (OTC) Analgesics Market Size (2021-2032)
- 2.2.2 Global Over the Counter (OTC) Analgesics Sales (2021-2032)
- 2.2.3 Global Over the Counter (OTC) Analgesics Market Average Price (2021-2032)
- 2.3 Over the Counter (OTC) Analgesics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.3.4 Other
- 2.4 Over the Counter (OTC) Analgesics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Over the Counter (OTC) Analgesics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Over the Counter (OTC) Analgesics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Over the Counter (OTC) Analgesics Revenue of Manufacturers (2021-2026)
- 3.4 Global Over the Counter (OTC) Analgesics Average Price by Manufacturers (2021-2026)
- 3.5 Global Over the Counter (OTC) Analgesics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Over the Counter (OTC) Analgesics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Over the Counter (OTC) Analgesics, Product Type & Application
- 3.8 Global Manufacturers of Over the Counter (OTC) Analgesics, Established Date
- 3.9 Global Over the Counter (OTC) Analgesics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceutical Company Limited.
- 4.1.1 Takeda Pharmaceutical Company Limited. Company Information
- 4.1.2 Takeda Pharmaceutical Company Limited. Business Overview
- 4.1.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
- 4.1.5 Takeda Pharmaceutical Company Limited. Recent Developments
- 4.2 Sanofi SA
- 4.2.1 Sanofi SA Company Information
- 4.2.2 Sanofi SA Business Overview
- 4.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
- 4.2.5 Sanofi SA Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Bayer AG
- 4.6.1 Bayer AG Company Information
- 4.6.2 Bayer AG Business Overview
- 4.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
- 4.6.5 Bayer AG Recent Developments
- 4.7 AstraZeneca
- 4.7.1 AstraZeneca Company Information
- 4.7.2 AstraZeneca Business Overview
- 4.7.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
- 4.7.5 AstraZeneca Recent Developments
- 4.8 Sun Pharma
- 4.8.1 Sun Pharma Company Information
- 4.8.2 Sun Pharma Business Overview
- 4.8.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
- 4.8.5 Sun Pharma Recent Developments
- 4.9 Reckitt Benckiser Group PLC
- 4.9.1 Reckitt Benckiser Group PLC Company Information
- 4.9.2 Reckitt Benckiser Group PLC Business Overview
- 4.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
- 4.9.5 Reckitt Benckiser Group PLC Recent Developments
- 4.10 GlaxoSmithKline PLC
- 4.10.1 GlaxoSmithKline PLC Company Information
- 4.10.2 GlaxoSmithKline PLC Business Overview
- 4.10.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
- 4.10.5 GlaxoSmithKline PLC Recent Developments
- 4.11 Boehringer Ingelheim International GmbH
- 4.11.1 Boehringer Ingelheim International GmbH Company Information
- 4.11.2 Boehringer Ingelheim International GmbH Business Overview
- 4.11.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
- 4.11.5 Boehringer Ingelheim International GmbH Recent Developments
5 Global Over the Counter (OTC) Analgesics Market Scenario by Region
- 5.1 Global Over the Counter (OTC) Analgesics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Over the Counter (OTC) Analgesics Sales by Region: 2021-2032
- 5.2.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2021-2026
- 5.2.2 Global Over the Counter (OTC) Analgesics Sales by Region: 2027-2032
- 5.3 Global Over the Counter (OTC) Analgesics Revenue by Region: 2021-2032
- 5.3.1 Global Over the Counter (OTC) Analgesics Revenue by Region: 2021-2026
- 5.3.2 Global Over the Counter (OTC) Analgesics Revenue by Region: 2027-2032
- 5.4 North America Over the Counter (OTC) Analgesics Market Facts & Figures by Country
- 5.4.1 North America Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
- 5.4.3 North America Over the Counter (OTC) Analgesics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Over the Counter (OTC) Analgesics Market Facts & Figures by Country
- 5.5.1 Europe Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
- 5.5.3 Europe Over the Counter (OTC) Analgesics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Over the Counter (OTC) Analgesics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Over the Counter (OTC) Analgesics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Over the Counter (OTC) Analgesics Market Facts & Figures by Country
- 5.7.1 South America Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
- 5.7.3 South America Over the Counter (OTC) Analgesics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Over the Counter (OTC) Analgesics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Over the Counter (OTC) Analgesics Sales by Type (2021-2032)
- 6.1.1 Global Over the Counter (OTC) Analgesics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2021-2032)
- 6.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2021-2032)
- 6.2.1 Global Over the Counter (OTC) Analgesics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2021-2032)
- 6.3 Global Over the Counter (OTC) Analgesics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Over the Counter (OTC) Analgesics Sales by Application (2021-2032)
- 7.1.1 Global Over the Counter (OTC) Analgesics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2021-2032)
- 7.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2021-2032)
- 7.2.1 Global Over the Counter (OTC) Analgesics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2021-2032)
- 7.3 Global Over the Counter (OTC) Analgesics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Over the Counter (OTC) Analgesics Value Chain Analysis
- 8.1.1 Over the Counter (OTC) Analgesics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Over the Counter (OTC) Analgesics Production Mode & Process
- 8.2 Over the Counter (OTC) Analgesics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Over the Counter (OTC) Analgesics Distributors
- 8.2.3 Over the Counter (OTC) Analgesics Customers
9 Global Over the Counter (OTC) Analgesics Analyzing Market Dynamics
- 9.1 Over the Counter (OTC) Analgesics Industry Trends
- 9.2 Over the Counter (OTC) Analgesics Industry Drivers
- 9.3 Over the Counter (OTC) Analgesics Industry Opportunities and Challenges
- 9.4 Over the Counter (OTC) Analgesics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst